Sanofi (SNY) ADR Ech Rep 1/2 Ord

Sell:$53.87Buy:$53.89$0.38 (0.71%)

NASDAQ:0.27%
Prices delayed by at least 15 minutes
Sell:$53.87
Buy:$53.89
Change:$0.38 (0.71%)
Deal now
Prices delayed by at least 15 minutes
Sell:$53.87
Buy:$53.89
Change:$0.38 (0.71%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.

Key people

Paul Hudson
Chief Executive Officer, Executive Director, Member of the Executive Committee
Francois-Xavier Roger
Chief Financial Officer, Member of the Executive Committee
Natalie Bickford
Chief People Officer, Executive Vice President, Member of the Executive Committee
Roy Papatheodorou
Executive Vice President, General Counsel, Member of the Executive Committee
Houman Ashrafian
Executive Vice President, Head of Research and Development, Member of the Executive Committee
Olivier Charmeil
Executive Vice President - General Medicines, Member of the Executive Committee
Audrey Duval Derveloy
Executive Vice President, Global Head of Corporate Affairs, Member of the Executive Committee
Emmanuel Frenehard
Executive Vice President, Chief Digital Officer, Member of the Executive Committee
Brendan O'Callaghan
Executive Vice President - Global Manufacturing and Supply, Member of the Executive Committee
Madeleine Roach
Executive Vice President, Business Operations, Member of the Executive Committee
Frederic Oudea
Independent Chairman of the Board
Christophe Babule
Director
Wolfgang Laux
Director, Employee Representative
Barbara Lavernos
Director
Tran Yann
Director, Employee Representative
Click to see more

Key facts

  • EPIC
    -
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US80105N1054
  • Market cap
    $136.72bn
  • Employees
    87,994
  • Shares in issue
    1.26bn
  • Exchange
    Euronext Paris
  • Index
    CAC 40 Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.